Status | Study |
Recruiting |
Study Name: Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis Condition: Granulomatosis, Wegener's Microscopic Polyangiitis Date: 2015-06-10 Interventions: Other: blood specimen blood specimen for serum rituximab level and serum anti-rituximab level at M1 and |
Recruiting |
Study Name: Low-dose Glucocorticoid Vasculitis Induction Study Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Microscopic Date: 2014-07-18 Interventions: Drug: Rituximab Patients will |
Active, not recruiting |
Study Name: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis Condition: Granulomatosis With Polyangiitis Microscopic Polyangiitis Date: 2014-06-19 Interventions: Drug: Glucocorticoids |
Recruiting |
Study Name: A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis Condition: Wegener's Granulomatosis or Microscopic Polyangiitis Date: 2014-04-14 Interventions: Drug: Methylprednisolone Methy |
Active, not recruiting |
Study Name: A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Condition: Granulomatosis With Polyangiitis Date: 2012-12-13 Interventions: Drug: Rituximab Participants will receive rituximab 375 mg/m^2 IV infusion on Days 1, 8, 15 and 22. Ritu |
Active, not recruiting |
Study Name: PRO Development for ANCA Associated Vasculitis Condition: Wegener Granulomatosis Microscopic Polyangiitis Date: 2012-10-25 |
Active, not recruiting |
Study Name: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis Condition: Granulomatosis With Polyangiitis Microscopic Polyangiitis Date: 2012-10-12 Interventions: Drug: Rituximab (Arm B) Rituxi |
Active, not recruiting |
Study Name: Rituximab Vasculitis Maintenance Study Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Microscopic Date: 2012-08-31 Interventions: Biological: Rituximab Rituxima |
Completed |
Study Name: Belimumab in Remission of VASculitis Condition: Vasculitis Date: 2012-08-09 Interventions: Biological: Placebo Placebo |
Active, not recruiting |
Study Name: An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Condition: Granulomatosis With Polyangiitis Microscopic Polyangiitis Date: 2012-06-04 Interventions: Drug: Rituximab Participants received rituximab at the discretion of their treating physicians. |